 |
Alterity Therapeutics Limited
ATHE
|
16.2 K |
$ 3.66 |
-1.48 % |
$ 8.81 B |
Australia |
 |
I-Mab
IMAB
|
271 |
- |
- |
$ 866 M |
China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 |
- |
- |
$ 40.3 B |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
Midatech Pharma plc
MTP
|
204 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
70.9 |
$ 21.36 |
4.86 % |
$ 998 M |
USA |
 |
Acorda Therapeutics
ACOR
|
48.3 |
- |
-24.86 % |
$ 820 K |
USA |
 |
Adverum Biotechnologies
ADVM
|
222 |
- |
- |
$ 86.2 M |
USA |
 |
Advaxis
ADXS
|
88.1 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
AgeX Therapeutics
AGE
|
186 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
62.9 |
$ 1.47 |
5.0 % |
$ 378 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.114 |
- |
- |
$ 26.5 M |
USA |
 |
Aptinyx
APTX
|
46.9 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 |
$ 2.92 |
- |
$ 4.81 M |
Israel |
 |
Aquestive Therapeutics
AQST
|
103 |
$ 4.19 |
2.7 % |
$ 448 M |
USA |
 |
Aravive
ARAV
|
16.8 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
106 |
$ 24.12 |
-0.37 % |
$ 3.07 B |
USA |
 |
AIkido Pharma
AIKI
|
17.9 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Celldex Therapeutics
CLDX
|
321 |
$ 32.59 |
1.09 % |
$ 2.16 B |
USA |
 |
Autolus Therapeutics plc
AUTL
|
58.2 |
$ 1.47 |
-1.34 % |
$ 391 M |
Britain |
 |
Cidara Therapeutics
CDTX
|
2.26 K |
- |
- |
$ 1.41 B |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 |
- |
- |
$ 7.46 M |
Israel |
 |
CureVac N.V.
CVAC
|
13.6 |
- |
- |
$ 867 M |
Germany |
 |
BeiGene, Ltd.
BGNE
|
52.6 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
Esperion Therapeutics
ESPR
|
99.7 |
$ 2.22 |
2.3 % |
$ 461 M |
USA |
 |
Evogene Ltd.
EVGN
|
30 |
$ 0.82 |
1.13 % |
$ 27.9 M |
Israel |
 |
Baudax Bio
BXRX
|
126 |
- |
0.59 % |
$ 63 K |
USA |
 |
Alpine Immune Sciences
ALPN
|
154 |
- |
- |
$ 2.17 B |
USA |
 |
CymaBay Therapeutics
CBAY
|
182 |
- |
- |
$ 3.45 B |
USA |